SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Metas earnings report is driving attention: traders cite strong advertising growth and early Muse AI traction, but debate whether the heavy AI infrastructure spending, negative free cash flow, and new nonvoting share structure could require outside financing or dilute shareholders. The initial earnings optimism faded, with bulls pointing to the core business and bears focusing on spending and uncertain returns.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas earnings reaction centers on an adjusted-profit beat being overshadowed by flat revenue, weaker operating profitability, and uncertainty over spending and Optimus timelines; traders debate whether positive cash generation and FSD growth support the longer-term AI story. Speculation about a TeslaSpaceX merger adds another point of disagreement, with some seeing potential upside and others questioning the deals terms and execution.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

The FDA accepted Biohavens resubmitted application for Vyglxia (troriluzole) for spinocerebellar ataxia, setting a Q1 2027 decision goal and driving a sharp move in the shares. Traders are split: some view the review as renewed opportunity, while others stress that acceptance is not approval and cite the long path to potential commercialization.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokias Q3 results are driving discussion: sales and comparable operating profit beat expectations, with AI and cloud demand surging, but shares faced a sell the news reaction amid weaker free cash flow guidance and higher restructuring costs. Traders are divided between viewing the AI-network growth and Nvidia partnership as a longer-term opportunity and questioning whether orders can translate into cash and sustained returns.

Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1995 and is headquartered in Bethesda, MD.

Lockheed Martin Corp.

Lockheed Martin is drawing attention after its third-quarter earnings beat, raised 2026 outlook and record backlog reinforced the defense-demand story; traders are also discussing a proposed 10-year F-35 production framework. The reaction is broadly bullish, though some caution that F-35 cost and funding pressure could weigh on margins, and the framework still requires further approvals and funding.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBMs quarterly earnings beat and improved cash-flow outlook are drawing attention, but traders focused on the sharp post-earnings reversal and managements comments about customers scrutinizing AI spending returns. The reaction is split between buyers calling the selloff an overreaction and skeptics questioning margins, consulting growth, and whether AI demand will translate into lasting returns.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

Lam Researchs shares are drawing attention after falling despite record results, as traders focus on an outlook that disappointed high expectations, supplier constraints delaying shipments, and a projected decline in Chinas revenue contribution. The debate is whether these pressures signal weaker demand or a temporary timing and mix issue; some traders see a buying opportunity, citing strong longer-term AI and semiconductor-equipment demand.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Strong quarterly results, upbeat fiscal 2027 guidance and a substantial backlog tied to AI data-center and grid-power demand are driving attention, alongside analyst upgrades. Many traders are bullish on the growth outlook, while others question whether the sharp post-earnings move can hold amid volatile trading and concerns about selling pressure.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Stockholm, Sweden.

Spotify Technology S.A.

Spotifys Q3 results are driving discussion: traders are weighing missed earnings expectations against stronger subscriber growth, improving margins, and a Q4 profit outlook above estimates. The reaction is divided, with some focused on the guidance and resilience while others warn that the misses and higher operating costs could weigh on the stock.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines third-quarter results and outlook are driving discussion: record revenue and premium demand were offset by sharply higher fuel costs, with the company projecting continued losses. Traders are weighing resilient travel demand against fuel-cost pressure and the airlines debt burden.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer

(RTTNews) - On Friday, Outlook Therapeutics (OTLK), a biopharmaceutical company developing and commercializing LYTENAVA for retinal diseases, announced Greg DiPasquale as Chief Commercial Officer...

OTLK Q3 Earnings Call Maps LYTENAVA U.S. Launch and Sales Ramp

Outlook Therapeutics targets a year-end 2026 U.S. LYTENAVA launch, with $50M-$75M in first-year net revenues and a ramp tied to reimbursement.

Transcript: Outlook Therapeutics Q3 2026 Earnings Conference Call

Outlook Therapeutics (NASDAQ:OTLK) released third-quarter financial results and hosted an earnings call on Friday. Read the complete transcript below.
This transcript is brought to you by Benzinga APIs. For real-timeread more...

Outlook Therapeutics, Inc. (OTLK) Reports Q3 Loss, Lags Revenue Estimates

Outlook Therapeutics, Inc. (OTLK) delivered earnings and revenue surprises of 0.00% and -99.25%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Outlook Therapeutics Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Outlook Therapeutics (NASDAQ: OTLK) to release Q3 earnings on Aug. 14. Analysts expect a loss of 8 cents/share. Analysts rate it Neutral or Buy.read more...

Zealand Pharma A/S (ZLDPF) Surpasses Q2 Earnings and Revenue Estimates

Zealand Pharma AS (ZLDPF) delivered earnings and revenue surprises of +2,150.00% and +756.67%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Why Did OTLK Stock Crash In Pre-Market Today?

Equity

Outlook Therapeutics is looking to sell about 55.6 million common shares, accompanied by warrants, at a 10% discount over the stock’s closing price on Wednesday.

OTLK Up More Than 300% in 3 Months: Here's What You Should Know

Outlook Therapeutics rallies 311.8% in three months as Lytenava's FDA approval boosts optimism ahead of its planned U.S. launch by year-end.

iRhythm Holdings, Inc. (IRTC) Tops Q2 Earnings and Revenue Estimates

IRHYTHM HLDGS (IRTC) delivered earnings and revenue surprises of +5,900.00% and +2.18%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Outlook Therapeutics, Inc. (OTLK) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Outlook Therapeutics, Inc. (OTLK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

This account has been verified as an official OTLK representative.

Verified Account

Outlook Therapeutics

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.

Outlook Therapeutics Inc

Bullish Sentiment

<ul class="summary-bullets"><li>Outlook plans to use the funds, alongside its existing cash, to support the U.S. commercial launch of its eye drug Lytenava.</li><li>Lytenava received U.S. Food and Drug Administration approval for wet age-related macular degeneration last month.</li><li>Wall Street is expecting a third-quarter loss of $0.07 per share on Friday, narrower than last year’s $0.44 per share loss, according to Fiscal.ai.</li></ul>Shares of Outlook Therapeutics (OTLK) tanked nearly 24% in pre-market trading on Thursday, after the biotech firm announced a discounted share offering to fund the commercial launch of its recently approved eye drug in the U.S.<a href="https://stocktwits.com/symbol/OTLK">OTLK stock</a> is tracking its third successive decline.<h2 class="st-heading-2">Offering At A 10% Discount</h2>Outlook Therapeutics is looking to sell about 55.6 million common shares, each accompanied by a warrant to purchase another share, at a combined price of $0.99. This represents a 10% discount over the stock’s closing price on Wednesday.The warrants carry an exercise price of $1.10 and expire after five years. Underwriters also have a 30-day option to purchase up to 8.3 million additional shares and an equal number of warrants. The offering is expected to close on Aug. 14, 2026.Outlook expects gross proceeds of roughly $55 million, which it plans to use, alongside its existing cash, to support the U.S. commercial launch of Lytenava as well as for general corporate purposes.<h2 class="st-heading-2">Lytenava Set For U.S. Launch&nbsp;</h2>Last month, the U.S. Food and Drug Administration (FDA) <a href="https://stocktwits.com/news-articles/markets/equity/otlk-fda-wet-amd-drug-analysts-see-upside/cZZx4zAR7CX">approved</a> Lytenava for wet age-related macular degeneration. Outlook describes it as the only FDA-approved Bevacizumab formulation developed specifically for use in the eye.The approval marked a turnaround after the FDA rejected Outlook’s application in December 2025 and requested additional evidence. Following an appeal, the agency’s Office of New Drugs concluded in May that no further clinical trials were needed.Lytenava is already approved in the EU and U.K., and the company expects a U.S. launch before year-end.<h2 class="st-heading-2">OTLK Q3 Earnings Due Friday</h2>Meanwhile, the company reports third-quarter results on Friday, with Wall Street expecting a loss of $0.07 per share, narrower than last year’s $0.44 per share loss, according to Fiscal.ai. The stock has a 12-month price target of $5.40, according to Koyfin data, while three of the four analysts covering the stock have a ‘Buy’ rating and one ‘hold’ rating.<h2 class="st-heading-2">Retail Remains Bearish On OTLK</h2>Retail sentiment surrounding OTLK on Stocktwits remained in the ‘bearish’ zone over the past 24 hours, amid a 330% jump in message volumes.One user said the company didn’t raise enough funds.<stembedurl>https://stocktwits.com/HarmonyPioneer67/message/661747443</stembedurl>Another user felt the offering should have been carried out when the stock traded around $1.60.<stembedurl>https://stocktwits.com/Racsoracso/message/661743798</stembedurl>The stock has seen strong buying interest so far in 2026, gaining over 60%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Outlook Therapeutics is displayed on the screen of a smart tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

SPDR S&P Biotech ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.5613
Prev Close	$0.52
Open	$0.529
Dividend Yield	0.00%
50-Day Moving Average	$0.6369
Beta	0.97
Avg. Volume	4.4M
PE Ratio	-0.51

52-Week High	$2.54
52-Week Low	$0.1611
Market Capitalization	$136.65M
EPS (Annual)	-$1.79
Price to Book	-10.10
Revenue Per Employee	$83,149.12

Feed

News

Sentiment

Earnings

Fundamentals

Info

OTLK Fundamentals